Literature DB >> 3069475

Influence of a single dose of captopril on pulmonary haemodynamics and right ventricular function in mitral stenosis with pulmonary hypertension.

K Zmudka1, J P Dubiel, T Brzostek, T Horzela.   

Abstract

The response of the pulmonary circulation to captopril 75 mg has been examined in 21 patients with pulmonary hypertension secondary to mitral stenosis. The effects of captopril were measured every 15 min up to 2 h by recording pressures in the pulmonary and systemic circulations and by measuring cardiac output. Pulmonary artery systolic pressure fell significantly by 21.6% (from means = 54.6 to 42.8 mm Hg), pulmonary artery diastolic pressure by 23.3% (from 26.2 to 20.1 mm Hg), and the pulmonary artery mean pressure by 23.2% (from 36.9 to 28.3 mm Hg). Right ventricular end-diastolic pressure also fell significantly by 7% (8.1 to 7.5 mm Hg). Heart rate decreased by 6.5% (from 76.3 to 71.3 beats.min-1). Cardiac index and stroke volume index did not change. The total and vascular pulmonary resistance dropped significantly by 23.2% (from 721 to 553.7 dyn.s.cm-5) and 40% (from 287.2 to 172 dyn.s.cm-5), respectively. The right ventricular stroke work index fell by 33% (from 15.1 to 10.1 g/beat/m2). Systemic systolic pressure decreased by 10.5% (from 124.5 to 111.4 mm Hg). Thus, captopril lowered pulmonary pressures and resistances and no deterioration in right ventricular function was observed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3069475     DOI: 10.1007/bf00558238

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  20 in total

1.  Pulmonary hypertension with special reference to the vasoconstrictive factor.

Authors:  P WOOD
Journal:  Br Heart J       Date:  1958-10

2.  [Effect of angiotensin II on the pressure in the pulmonary circulation].

Authors:  S Pasyk; J Dubiel; E Telesz
Journal:  Acta Physiol Pol       Date:  1967

Review 3.  Angiotensin-converting enzyme inhibitors: past, present, and bright future.

Authors:  C R Edwards; P L Padfield
Journal:  Lancet       Date:  1985-01-05       Impact factor: 79.321

4.  Converting enzyme inhibitors in hypertension and heart failure.

Authors:  H J Dargie; S G Ball; A B Atkinson; J I Robertson
Journal:  Br Heart J       Date:  1983-04

5.  Effect of prostaglandin E1 (PGE1) and indomethacin on pulmonary circulation in man.

Authors:  J S Dubiel; J Szczeklik; M Mysik; Z Pyzik; H Gałuszka-Trybus; R Król; T Horzela
Journal:  Acta Med Pol       Date:  1979

6.  Effects of prostaglandin E1 on pulmonary circulation in patients with pulmonary hypertension.

Authors:  J Szczeklik; J S Dubiel; M Mysik; Z Pyzik; R Krol; T Horzela
Journal:  Br Heart J       Date:  1978-12

7.  Angiotensin II vascular receptors: their avidity in relationship to sodium balance, the autonomic nervous system, and hypertension.

Authors:  H R Brunner; P Chang; R Wallach; J E Sealey; J H Laragh
Journal:  J Clin Invest       Date:  1972-01       Impact factor: 14.808

8.  Long-term hemodynamic and clinical efficacy of captopril therapy in ambulatory management of severe chronic congestive heart failure.

Authors:  N A Awan; E A Amsterdam; J Hermanovich; W J Bommer; K E Needham; D T Mason
Journal:  Am Heart J       Date:  1982-04       Impact factor: 4.749

9.  Contrasting hemodynamic responses in severe heart failure: comparison of captopril and other vasodilator drugs.

Authors:  M Packer; N Medina; M Yushak
Journal:  Am Heart J       Date:  1982-11       Impact factor: 4.749

10.  Hemodynamic effects of captopril in pulmonary hypertension of collagen vascular disease.

Authors:  A P Niarchos; H H Whitman; J E Goldstein; J H Laragh
Journal:  Am Heart J       Date:  1982-10       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.